BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
1226 results:

  • 1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2).
    Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.
    Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
    Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
    BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).
    Ye X; Tuo Z; Chen K; Wu R; Wang J; Yu Q; Ye L; Miyamoto A; Yoo KH; Zhang C; Wei W; Li D; Feng D
    Oncol Res; 2024; 32(3):503-515. PubMed ID: 38361753
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
    Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
    J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. WT1 and tp53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia.
    Asghari-Ghomi A; Fallahian F; Garavand J; Mohammadi MH
    Mol Biol Rep; 2024 Feb; 51(1):244. PubMed ID: 38300383
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 9. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
    Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
    Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tissue Organoid Cultures Metabolize Dietary Carcinogens Proficiently and Are Effective Models for DNA Adduct Formation.
    Caipa Garcia AL; Kucab JE; Al-Serori H; Beck RSS; Bellamri M; Turesky RJ; Groopman JD; Francies HE; Garnett MJ; Huch M; Drost J; Zilbauer M; Arlt VM; Phillips DH
    Chem Res Toxicol; 2024 Feb; 37(2):234-247. PubMed ID: 38232180
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of Purine Metabolism-Related
    Yin W; Wang JH; Liang YM; Liu KH; Chen Y; Chen YS
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):354. PubMed ID: 38179759
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
    Kim GR; Kang JH; Kim HJ; Im E; Bae J; Kwon WS; Rha SY; Chung HC; Cho EY; Kim SY; Kim YC
    Bioorg Chem; 2024 Feb; 143():107061. PubMed ID: 38154386
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy.
    Wang R; Uzzo N; Chelluri R; Mackrides N; Ehya H; Pei J; Baldwin DA; Wasik MA; Wei S; Uzzo R
    Urology; 2024 Feb; 184():79-82. PubMed ID: 38128834
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The role of single-cell RNA sequencing in cardiac tumour - a case report.
    Qi XJ; Wei T; Abba IA; Zhang SQ; Meng JJ; Shi C; Jiang Y
    J Pak Med Assoc; 2023 Dec; 73(12):2462-2464. PubMed ID: 38083933
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma.
    Chen SA; Zhang JP; Wang N; Chen J
    Technol Cancer Res Treat; 2023; 22():15330338231194555. PubMed ID: 38043946
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
    Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
    Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.
    Su X; Lu X; Bazai SK; Dainese L; Verschuur A; Dumont B; Mouawad R; Xu L; Cheng W; Yan F; Irtan S; Lindner V; Paillard C; Le Bouc Y; Coulomb A; Malouf GG
    Nat Commun; 2023 Nov; 14(1):7884. PubMed ID: 38036539
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.
    Zhang X; Wang C; Shen D
    Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
    Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
    Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 62.